Dahan Michel insider trades
Dahan Michel has filed 9 Form 4s with the SEC that we hold, all for Akebia Therapeutics, Inc. (AKBA), as SVP, Chief Operating Officer. Across all of them we count 0 purchases worth $0 and 11 sales worth $248.2K reported on Form 4. None of these purchases or sales is dated in the last 12 months. The largest single trade was a sale of 95,478 shares of Akebia Therapeutics, Inc. worth $116.5K, dated 2023-05-25. The first filing on our record is dated 2022-03-02 and the latest 2024-05-14.
Akebia Therapeutics, Inc. (AKBA)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2022-02-28 | S, sale reported on Form 4 | 6,555 | $14.1K | 2022-03-02 |
| 2022-03-01 | S, sale reported on Form 4 | 6,873 | $14.9K | 2022-03-02 |
| 2022-03-01 | S, sale reported on Form 4 | 1,232 | $2.7K | 2022-03-02 |
| 2023-02-27 | S, sale reported on Form 4 | 10,090 | $8.2K | 2023-03-01 |
| 2023-03-01 | S, sale reported on Form 4 | 10,476 | $9.2K | 2023-03-03 |
| 2023-03-01 | S, sale reported on Form 4 | 8,058 | $7.1K | 2023-03-03 |
| 2023-03-01 | S, sale reported on Form 4 | 1,878 | $1.7K | 2023-03-03 |
| 2023-05-25 | S, sale reported on Form 4 | 95,478 | $116.5K | 2023-05-25 |
| 2024-02-27 | S, sale reported on Form 4 | 10,744 | $16.3K | 2024-02-29 |
| 2024-02-29 | S, sale reported on Form 4 | 8,661 | $13.7K | 2024-03-01 |
| 2024-05-13 | S, sale reported on Form 4 | 34,840 | $43.9K | 2024-05-14 |
Counted from the Form 4 filings this reporting owner (SEC CIK 1669737) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms